We report a middle-aged man with wheat-triggered adult-onset colitic FPIES in whom dupilumab produced rapid immunologic changes and durable clinical tolerance, providing proof-of-concept for successful IL-4Rα antagonism in non–IgE-mediated food allergy. This evidence concerns the gene IGHE and food allergy.